Bioengineered Nanospores Selectively Blocking LC3-Associated Phagocytosis in Tumor-Associated Macrophages Potentiate Antitumor Immunity
ACS Nano · 2023
DOI: 10.1021/acsnano.3c02657 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2023. Verfasst von Yunkai Shang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, Department of Pharmaceutics, China Pharma…. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: State Key Laboratory of Natural Medicines, ?333 Project? of Jiangsu Province, Double First Class University Plan.
Abstract (Originalsprache)
Although cytotoxic treatments hold tremendous potential in boosting antitumor immunity, efferocytosis of tumor-associated macrophages (TAMs) could negatively remove apoptotic tumor cells through LC3-associated phagocytosis (LAP), resulting in inefficient tumor antigen presentation and immunosuppressive tumor microenvironment. To address this issue, we developed TAM-targeting nanospores (PC-CW) inspired by the predominant tropism of Rhizopus oryzae toward macrophages. To construct PC-CW, we disguised poly(sodium-p-styrenesulfonate) (PSS)-coated polyethylenimine (PEI)-shRNA nanocomplexes with the cell wall of R. oryzae conidia. LAP blockade by PC-CW delayed the degradation of engulfed tumor debris within TAMs, which not only enhanced antigen presentation but also initiated the domino effect of the antitumor immune response through STING signaling and TAM repolarization. Benefiting from this, PC-CW successfully sensitized the immune microenvironment and amplified CD8+ T cell responses following chemo-photothermal therapy, leading to substantial tumor growth control and metastasis prevention in tumor-bearing mouse models. The bioengineered nanospores represent a simple and versatile immunomodulatory strategy targeting TAMs for robust antitumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, People's Rep…
Förderung
- State Key Laboratory of Natural Medicines
- ?333 Project? of Jiangsu Province
- Double First Class University Plan
- Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University
Zitieren
APA
Shang, Y., Lu, H., Liao, L., Li, S., Xiong, H., & Yao, J. (2023). Bioengineered Nanospores Selectively Blocking LC3-Associated Phagocytosis in Tumor-Associated Macrophages Potentiate Antitumor Immunity. ACS Nano. https://doi.org/10.1021/acsnano.3c02657
Vancouver
Shang Y, Lu H, Liao L, Li S, Xiong H, Yao J. Bioengineered Nanospores Selectively Blocking LC3-Associated Phagocytosis in Tumor-Associated Macrophages Potentiate Antitumor Immunity. ACS Nano. 2023. doi:10.1021/acsnano.3c02657
BibTeX
@article{Shang2023,
author = {Shang, Yunkai and Lu, Haipeng and Liao, Li and Li, Suxin and Xiong, Hui and Yao, Jing},
title = {Bioengineered Nanospores Selectively Blocking LC3-Associated Phagocytosis in Tumor-Associated Macrophages Potentiate Antitumor Immunity},
journal = {ACS Nano},
year = {2023},
doi = {10.1021/acsnano.3c02657}
}
EUVIMED